logo
ENTITY
Astellas Pharma

Astellas Pharma (4503 JP)

134
Analysis
Health Care • Japan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of Urology, Immunology including Transplantation and Infectious Diseases, Oncology, Neuroscience and DM Complications and Metabolic Diseases. With over 17,000 global employees, Astellas researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia
more
bullish•Astellas Pharma
•31 Oct 2018 22:56

Astellas 1H FY18 (YE Mar'19) Results - First Glance

Key highlights Key drivers including, Xtandi (up 17% to ¥164b) and Mirabegron (up 19% to ¥69b) drove overall sales up by 1% to ¥647b Favorable...

Logo
Share
bullish•Thematic (Sector/Industry)
•28 Sep 2018 18:05

Japan CAR-T Therapy Landscape

Japan CAR-T therapy - Competitive landscapeJapan pharma catching-up with global players… but a large gap remains Novartis AG (NOVN SE)’ Kymriah...

Logo
Share
bullish•Thematic (Sector/Industry)
•25 Sep 2018 19:48

Japan Pharma: Core Coverage Investment Thesis and Valuations (III/​III)

Takeda Pharmaceutical (4502 JP), Astellas Pharma (4503 JP), Daiichi Sankyo (4568 JP), Eisai Co Ltd (4523 JP), Otsuka Holdings (4578 JP), Chugai...

Logo
Share
bullish•Thematic (Sector/Industry)
•25 Sep 2018 19:43

Japan Pharma: Core Coverage Investment Thesis and Valuations (II/​III)

Takeda Pharmaceutical (4502 JP), Astellas Pharma (4503 JP), Daiichi Sankyo (4568 JP), Eisai Co Ltd (4523 JP), Otsuka Holdings (4578 JP), Chugai...

Logo
Share
bullish•Thematic (Sector/Industry)
•25 Sep 2018 19:38

Japan Pharma: Core Coverage Investment Thesis and Valuations (I/III)

Takeda Pharmaceutical (4502 JP), Astellas Pharma (4503 JP), Daiichi Sankyo (4568 JP), Eisai Co Ltd (4523 JP), Otsuka Holdings (4578 JP), Chugai...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.41.3

x